Industry News

Rib-X Pharmaceuticals is planning a new 26,400-sf lab and office facility at New Haven’s 300 George Biotech Laboratory complex. Jung/Brannen Associates, based in Boston, has completed architectural design for the structure, which will accommodate research, a computational chemistry lab, facilities for wet-lab chemistry, and administrative offices.

The Los Angeles Regional Crime Laboratory Facility Authority has selected the architectural team of HarleyEllis of Detroit and their Los Angeles affiliate Fields Deveraux Architects Engineers to program the new Los Angeles Regional Forensics Science Crime Laboratory.

Merck & Co. is planning a new 300,000-gsf biotechnology research facility on the campus of Emmanuel College in Boston’s Fenway neighborhood. Designated as Merck Research Laboratories-Boston, the structure will have twelve stories above ground and six below, and will house scientists, support staff, and administrative personnel when it opens in 2004.

The University of Medicine & Dentistry of New Jersey has selected Sordoni Skanska of Parsippany, N.J., to manage construction for a 139,000-gsf expansion of the Cancer Institute of New Jersey’s current cancer facility. The Institute is located on the New Brunswick campus of Robert Wood Johnson Medical School. Construction on the $46.7-million, five-story project began in February 2002; completion is expected by December 2003. The expansion will add space for research, patient treatment, cancer prevention and education programs.

Advanced Micro Devices (AMD) announced in January that it plans to build its new 300mm chipmaking fabrication plant in Singapore, rather than in Texas or another U.S. location, despite significant efforts by many cities to draw the project to their region. AMD will partner with United Microelectronics Corp., based in Taiwan, to spread the costs of building the fab.